|
SF3B3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.655400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.424000E-01 |
| Normal-vs-Stage2 |
3.055800E-01 |
| Normal-vs-Stage3 |
2.177000E-01 |
| Normal-vs-Stage4 |
1.756410E-01 |
| Stage1-vs-Stage2 |
4.212200E-02 |
| Stage1-vs-Stage3 |
7.742200E-03 |
| Stage1-vs-Stage4 |
7.623700E-03 |
| Stage2-vs-Stage3 |
9.816400E-01 |
| Stage2-vs-Stage4 |
8.240400E-01 |
| Stage3-vs-Stage4 |
8.150800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.374800E-01 |
| Normal-vs-AfricanAmerican |
1.146000E-01 |
| Normal-vs-Asian |
6.196600E-01 |
| Caucasian-vs-AfricanAmerican |
7.711500E-02 |
| Caucasian-vs-Asian |
6.506600E-01 |
| AfricanAmerican-vs-Asian |
2.767000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.699600E-01 |
| Normal-vs-Female |
9.851800E-01 |
| Male-vs-Female |
6.126000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.328000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.278400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.256400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.394370E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.859000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.697600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.838000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.400500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.440200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.845600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.992500E-02 |
| Normal-vs-Grade 2 |
5.566800E-01 |
| Normal-vs-Grade 3 |
4.041200E-01 |
| Normal-vs-Grade 4 |
1.400760E-01 |
| Grade 1-vs-Grade 2 |
6.480500E-02 |
| Grade 1-vs-Grade 3 |
2.382200E-02 |
| Grade 1-vs-Grade 4 |
1.399930E-02 |
| Grade 2-vs-Grade 3 |
6.402300E-02 |
| Grade 2-vs-Grade 4 |
1.651720E-02 |
| Grade 3-vs-Grade 4 |
3.390800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.029000E-01 |
| Normal-vs-ccB subtype |
5.845400E-01 |
| ccA subtype-vs-ccB subtype |
2.977900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.789800E-01 |
| Normal-vs-N1 |
9.141200E-01 |
| N0-vs-N1 |
8.403000E-01 |
|
|
